Navin Fluorine Reports Strong Q2 FY26 Results, Declares Interim Dividend, and Approves ₹311.5 Crore Capex
Navin Fluorine reported strong Q2 FY26 results with significant revenue and profit growth. The company declared an interim dividend and approved ₹311.5 crore capex for HFC expansion and MPP debottlenecking, funded internally.
The announcement includes strong quarterly and half-yearly financial results, a dividend declaration, and significant strategic capital expenditure plans that are expected to drive future revenue growth and consolidate market position, indicating a high impact on the company's prospects.
The announcement shows strong financial performance with significant increases in revenue, EBITDA, and PAT. The declaration of an interim dividend and approval of substantial strategic capex for future growth further contribute to a positive outlook.
Navin Fluorine International Limited announced the release of the transcript from its earnings call held on October 30, 2025, discussing the operational and financial performance for the quarter and half year ended September 30, 2025 (Q2 & H1 of FY 2025-26). * Financial Performance (Consolidated Q2 FY26 vs. Q2 FY25): * Revenue increased by 46% to ₹758 crores. * Operating EBITDA grew by 129% to ₹246 crores, with margins at 32.5% (up from 20.7%). * Profit after tax more than doubled to ₹148 crores. * Financial Performance (Consolidated H1 FY26 vs. H1 FY25): * Net operating revenues rose by 42% to ₹1,484 crores. * Operating EBITDA stood at ₹453 crores, with margins at 30.5% (up from 19.9%). * Profit after tax increased by 141% to ₹266 crores. * Dividend Declaration: The Board declared an interim dividend of ₹6.5 per share on a face value of ₹2 per share. * Strategic Capex Approvals: The Board approved two strategic capexes totaling ₹311.5 crores: * HFC Capacity Expansion: ₹236.5 crores for setting up additional HFC capacity equivalent to 15,000 metric tonnes per annum of R32. This asset is expected to generate a peak annual revenue of ₹600 crores to ₹825 crores and is projected to be commissioned by Q3 FY27. * MPP Debottlenecking: ₹75 crores for debottlenecking MPP capacity at Dahej, expected to contribute ₹140 crores to ₹160 crores per annum on completion, with a target commissioning date of Q3 FY27. * Both capexes will be funded through internal accruals. * Business Segment Highlights: All three business divisions (HPP, Specialty, CDMO) reported good growth in Q2 FY26. The AHF project is advancing, with mechanical trials underway and expected commissioning by Q3 FY26. The Chemours project is on track for completion by Q1 FY27. CDMO revenue grew by 98% year-on-year to ₹134 crores in Q2 FY26, with supplies from the cGMP4 plant expected to commence from January 2026. * Management Outlook: The company aims for a full-year EBITDA margin between 28% to 30% for FY26, citing strong volume growth, product mix, and efficiencies as key drivers. Net debt-to-equity ratio stands at 0.9x as of September 30, 2025.
What to do with a filing like this
Navin Fluorine International Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Navin Fluorine International Limited. Read the original for the full detail.